Search research articles
Contact Us
Filters
Showing results (11-20 of 223) with videos related to
Page
of 23
Sort By:
The Oncologist
|
February 23, 2011
Castration-resistant prostate cancer: targeted therapies and individualized treatment
Rahul Aggarwal, Charles J Ryan
Prostate Cancer and Prostatic Diseases
|
August 23, 2018
BRCAness and prostate cancer: diagnostic and therapeutic considerations
Mallika Dhawan, Charles J Ryan
The Journal of Urology
|
October 2, 2010
Editorial comment
Terence W Friedlander, Charles J Ryan
Prostate Cancer and Prostatic Diseases
|
May 26, 2021
Novel immune engagers and cellular therapies for metastatic castration-resistant prostate cancer: do we take a BiTe or ride BiKEs, TriKEs, and CARs?
Nicholas A Zorko, Charles J Ryan
Current Oncology Reports
|
April 2, 2009
Novel hormonal approaches in prostate cancer
Terence W Friedlander, Charles J Ryan
Current Opinion in Oncology
|
April 8, 2004
Advances in prostate cancer
Charles J Ryan, Eric J Small
Expert Opinion on Pharmacotherapy
|
December 4, 2012
Abiraterone acetate for the treatment of prostate cancer
Charles J Ryan, Michael L Cheng
European Urology
|
January 16, 2019
Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making
Alicia K Morgans, Charles J Ryan
Expert Opinion on Investigational Drugs
|
December 22, 2007
Novel therapeutic strategies in development for prostate cancer
Andrea L Harzstark, Charles J Ryan
The Journal of Urology
|
November 7, 2006
High risk biochemical relapse and the timing of androgen deprivation therapy
Charles J Ryan, Eric J Small
Page
of 23
Search research articles
Search
Showing results (11-20 of 223) with videos related to
Sort By:
Page
of 23
The Oncologist
|
February 23, 2011
Castration-resistant prostate cancer: targeted therapies and individualized treatment
Rahul Aggarwal, Charles J Ryan
Prostate Cancer and Prostatic Diseases
|
August 23, 2018
BRCAness and prostate cancer: diagnostic and therapeutic considerations
Mallika Dhawan, Charles J Ryan
The Journal of Urology
|
October 2, 2010
Editorial comment
Terence W Friedlander, Charles J Ryan
Prostate Cancer and Prostatic Diseases
|
May 26, 2021
Novel immune engagers and cellular therapies for metastatic castration-resistant prostate cancer: do we take a BiTe or ride BiKEs, TriKEs, and CARs?
Nicholas A Zorko, Charles J Ryan
Current Oncology Reports
|
April 2, 2009
Novel hormonal approaches in prostate cancer
Terence W Friedlander, Charles J Ryan
Current Opinion in Oncology
|
April 8, 2004
Advances in prostate cancer
Charles J Ryan, Eric J Small
Expert Opinion on Pharmacotherapy
|
December 4, 2012
Abiraterone acetate for the treatment of prostate cancer
Charles J Ryan, Michael L Cheng
European Urology
|
January 16, 2019
Hard Problems Need "Soft" Science: Integrating Quality of Life into Treatment Decision Making
Alicia K Morgans, Charles J Ryan
Expert Opinion on Investigational Drugs
|
December 22, 2007
Novel therapeutic strategies in development for prostate cancer
Andrea L Harzstark, Charles J Ryan
The Journal of Urology
|
November 7, 2006
High risk biochemical relapse and the timing of androgen deprivation therapy
Charles J Ryan, Eric J Small
Page
of 23